IRCT20140305016852N4
Recruiting
Phase 2
Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test (Kovid-19)
Sabzevar University of Medical Sciences0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Coronavirus disease (covid-19).
- Sponsor
- Sabzevar University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patient was admitted to the acute respiratory center
- •Consent to participate in the study
- •Age 15 to above
- •Do not take vitamin C and D supplements
- •Lack of kidney and liver disease
- •No pregnancy or lactation
- •No treatment with anti convulsants
Exclusion Criteria
- •The patient has lung cancer
- •Patients undergoing chemotherapy and radiotherapy
- •If the patient dies
- •If the patient has a decreased level of consciousness
- •If the patient does not want to continue working on the plan
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Treatments of Idiopathic Granulomatous MastitisIRCT20160101025791N3Kermanshah University of Medical Sciences150
Completed
Not Applicable
Comparison of three methods of treatment by using plate in the treatment of mandibular fractureFracture of mandible.Fracture of mandibleIRCT2017052834186N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences45
Active, not recruiting
Phase 1
Comparison of Two Different Treatment Strategies in Patients with Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy - HMGDMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-002319-42-SEEli Lilly and Company Limited1,160
Active, not recruiting
Phase 1
Comparison of Two Different Treatment Strategies in Patients with Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy - HMGDMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-002319-42-SIEli Lilly and Company Limited1,160
Active, not recruiting
Phase 1
Comparison of Two Different Treatment Strategies in Patients with Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy - HMGD(a)EUCTR2008-002319-42-FREli Lilly and Company Limited1,160